AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2024
Mar 20, 2024
30826_dirs_2024-03-20_a8fdb52f-5b3e-40e5-81ca-08196e84dd57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-03-18
Reporting Person: Hunt Anthony (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-18 | Common Stock | G | 2000 | $0.00 | Disposed | 183249 | Direct |
Footnotes
F1: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23